Valeo Financial Advisors’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-255
Closed -$8K – 883
2021
Q1
$8K Buy
255
+125
+96% +$3.84K ﹤0.01% 1415
2020
Q4
$4K Sell
130
-250
-66% -$7.63K ﹤0.01% 1405
2020
Q3
$11K Sell
380
-666
-64% -$16.9K ﹤0.01% 1058
2020
Q2
$22K Buy
1,046
+544
+108% +$12K ﹤0.01% 1020
2020
Q1
$12K Buy
502
+350
+230% +$9.59K ﹤0.01% 1024
2019
Q4
$4K Sell
152
-978
-87% -$26.6K ﹤0.01% 1337
2019
Q3
$30K Sell
1,130
-300
-21% -$9K ﹤0.01% 742
2019
Q2
$48K Buy
1,430
+1,130
+377% +$36.7K 0.01% 613
2019
Q1
$10K Hold
300
– – ﹤0.01% 960
2018
Q4
$9K Hold
300
– – ﹤0.01% 903
2018
Q3
$9K Buy
+300
New +$10.6K ﹤0.01% 995

Other funds holding ELAN

Valeo Financial Advisors's ELAN Position: Q2 2021 in Review

Valeo Financial Advisors sold out of Elanco Animal Health (ELAN) in Q2 2021, closing a stake of 255 shares — an estimated $8K sold.

Valeo Financial Advisors first reported a position in ELAN in Q3 2018 and held it in 11 quarters. The position peaked at $48K in Q2 2019. 479 funds tracked by Wall St. Rank hold ELAN as of Q2 2021.

  • Valeo Financial Advisors reported no remaining Elanco Animal Health position as of Q2 2021 after selling out during the quarter.
  • Valeo Financial Advisors sold 255 Elanco Animal Health shares in Q2 2021, an estimated $8K.
  • Valeo Financial Advisors first reported a position in Elanco Animal Health in Q3 2018 and held it in 11 quarters.
  • Valeo Financial Advisors's Elanco Animal Health position peaked at $48K in Q2 2019.
  • 479 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2021.

Based on Valeo Financial Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.